Have a personal or library account? Click to login
Evaluation of a new solid-phase immunoassay for alloantibody detection using bromelin-treated and untreated red blood cells Cover

Evaluation of a new solid-phase immunoassay for alloantibody detection using bromelin-treated and untreated red blood cells

By: T. Tamai and  T. Mazda  
Paid access
|Oct 2020

Abstract

The enzyme test is used to detect certain antibodies or facilitate antibody identification. This study compares antibody reactivity with bromelin-treated red blood cells (RBCs) and untreated RBCs using a newly developed solid-phase immunoassay. The reactivity of irregular antibodies was tested by a magnetic-mixed passive hemagglutination assay (M-MPHA). In addition, antibody reactivity was tested with dried stroma of bromelin-treated RBCs and untreated RBCs (M-MPHA-Dry). Rh antibodies were detected with enzyme-treated intact RBCs and untreated RBCs by M-MPHA. The slight increase in reactivity using M-MPHA was not seen using dried RBC stroma (M-MPHA-Dry). All donor-derived IgG alloantibodies, which were detected by either a conventional tube enzyme test or an indirect antiglobulin test, were detected by M-MPHA without using enzyme-treated RBCs. Both M-MPHA and M-MPHA-Dry can be used for antibody detection without using enzyme-treated RBCs and are also useful for antibody identification. Immunobematology 2OOI;I7:I7—21.

DOI: https://doi.org/10.21307/immunohematology-2019-536 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 17 - 21
Published on: Oct 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 T. Tamai, T. Mazda, published by American National Red Cross
This work is licensed under the Creative Commons License.